Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
Autoren
Lee S, Monz BU, Clemens A, Brueckmann M, Lip GYH
Journal
BMJ Open
Veröffentlichungsdatum
2012
Impact Factor
1.583
Abstract
Weitere IDs
Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens